10x Genomics Inc.
TXG | NASDAQ
$82.50
+$3.40 (+4.30%)
Sep 22, 2026, 12:43 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -46.60 | -9.45 | -25.67 | -24.96 | -281.06 | -26.37 |
PEG Ratio | 0.61 | 0.31 | -0.52 | -0.14 | 3.12 | -0.05 |
PS Ratio | 3.17 | 2.83 | 10.60 | 8.03 | 33.51 | 47.93 |
PB Ratio | 2.56 | 2.44 | 8.85 | 5.15 | 20.11 | 19.38 |
P/FCF Ratio | 15.64 | -301.92 | -101.30 | -25.10 | -134.02 | -55.89 |
P/OCF Ratio | 14.96 | 259.56 | -431.44 | -123.46 | -769.07 | -65.73 |
OCF/S Ratio | 21.16 | 1.09 | -2.46 | -6.51 | -4.36 | -72.91 |
Debt / Equity Ratio | 0.20 | 0.12 | 0.13 | 0.12 | 0.10 | 0.09 |
Quick Ratio | 4.09 | 4.26 | 4.11 | 4.23 | 6.23 | 6.30 |
Current Ratio | 4.46 | 4.97 | 4.69 | 4.85 | 6.77 | 6.56 |
Asset Turnover | 0.62 | 0.66 | 0.64 | 0.50 | 0.48 | 0.32 |
Interest Coverage | n/a | -48.64K | -8.04K | -352.82 | -61.10 | -50.73 |
Return on Equity | -5.47% | -25.72% | -34.42% | -20.60% | -7.12% | -73.43% |
Return on Assets | -4.18% | -19.88% | -26.43% | -16.13% | -5.71% | -58.40% |
Return on Invested Capital | -12.34% | -24.01% | -31.23% | -18.52% | -5.79% | -10.44% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 69.05% | 67.86% | 66.15% | 76.69% | 84.89% | 80.44% |
Net Profit Margin | -6.77% | -29.90% | -41.23% | -32.15% | -11.87% | -181.61% |
Pretax Profit Margin | -6.21% | -29.09% | -40.21% | -31.36% | -10.95% | -178.85% |
Operating Profit Margin | -17.25% | -31.85% | -42.88% | -32.52% | -10.79% | -28.55% |
FCF Margin | 20.24% | -0.94% | -10.46% | -32% | -25.01% | -85.76% |
EBITDA Margin | 0.61% | -21.94% | -33.15% | -24.88% | -5.01% | -171.92% |
Add to Watchlist
Select watchlists to add or remove TXG